The celebration of the 200th anniversary of TZF Polfa was held under the honorary patronage of the President of the Republic of Poland, Andrzej Duda.
The Ministry of Funds and Regional Policy granted funding with a total value of almost PLN 8 million to TZF Polfa. They will be used to build the Research and Development Center (worth over PLN 78 million) and to modernize the laboratory for the control and certification of FFP2 and FFP3 surgical masks and protective half-masks.
TZF Polfa is currently in talks with two Western pharmaceutical companies regarding bottling Covid-19 vaccines on an ampoule line. This is the last stage of production - packaging the finished product into ampoules.
Polfa Tarchomin offers the possibility of producing sterile medicinal products in the form of solutions based on water and/or organic solvents in ampoules in the new Sterile Forms Production Department, which will be launched this year:
The Ministry of Funds and Regional Policy granted funding with a total value of almost PLN 8 million to TZF Polfia. They will be used to build the Research and Development Center (worth over PLN 78 million) and to modernize the laboratory for the control and certification of FFP2 and FFP3 surgical masks and protective half-masks.
Attached are details of the quality standards met by disinfectants offered by Polfa Tarchomin and information about the type of marketing authorization.
TZF Polfa has become the official partner of Professional Disinfection of Ekstraklasa. As part of the cooperation, the company placed automatic dispensers with Trisept MAX hand disinfectant at sixteen PKO Bank Polski Ekstraklasa stadiums. The company promotes the use of disinfectants with virucidal, bactericidal and fungicidal properties.